NCT06944522 - A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

June 17, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2032

Conditions

Parkinsons Disease (PD)

Interventions

BIOLOGICAL

bemdaneprocel

Investigational cell therapy comprising midbrain dopaminergic neuron progenitors derived from human embryonic stem cells

PROCEDURE

Sham surgery

Sham surgery will be performed on Day 0

Trial Locations (10)

10065

RECRUITING

New York Presbyterian/Weill Cornell Medical Center, New York

20007

RECRUITING

MedStar Georgetown University Hospital, Washington D.C.

33136

RECRUITING

University of Miami Health System - Neurology, Miami

33486

RECRUITING

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

48334

RECRUITING

Quest Research Institute, Farmington Hills

60611

RECRUITING

Parkinson's Disease and Movement Disorders Center at Northwestern Memorial Hospital, Chicago

66160-8500

RECRUITING

University of Kansas Medical Center, Kansas City

02111

RECRUITING

Tufts Medical Center - Neurology, Boston

02903

RECRUITING

Rhode Island Hospital - Neurology, Providence